Body Mass Index and Prognostic Nutritional Index as Indicators of Treatment Adherence and Survival Outcomes in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Undergoing Sequential Chemoradiotherapy - Top-Institutions - MDSpire

Body Mass Index and Prognostic Nutritional Index as Indicators of Treatment Adherence and Survival Outcomes in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Undergoing Sequential Chemoradiotherapy

  • By

  • Esra Zeynelgil

  • Engin Eren Kavak

  • İsmail Dilli

  • Özlem Aydın İsak

  • Doğan Yazılıtaş

  • Gökşen İnanç İmamoğlu

  • Ömer Bayır

  • December 15, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Head and Neck Oncology
    • Radiation Oncology
    • Medical Oncology
    • Nutrition Support

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Head and Neck Surgery
    • Medical Oncology
    • Radiation Oncology
    • Nutrition and Metabolism

  • #3

    Dana-Farber Cancer Institute / Brigham and Women’s Hospital
    Dana-Farber Cancer Institute / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Radiation Oncology
    • Head and Neck Oncology
    • Clinical Nutrition

  • #4

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Head and Neck Oncology
    • Radiation Oncology
    • Medical Oncology
    • Nutrition

Original Source(s)

Body Mass Index and Prognostic Nutritional Index as Indicators of Treatment Adherence and Survival Outcomes in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Undergoing Sequential Chemoradiotherapy

  • by Esra Zeynelgil, Engin Eren Kavak, İsmail Dilli, Özlem Aydın İsak, Doğan Yazılıtaş, Gökşen İnanç İmamoğlu, Ömer Bayır

  • December 15, 2025

Related Content

A model combining deep learning and ensemble learning for melanoma recognition via dermoscopy

Real-world healthcare resource use and costs associated with the management of locally advanced head and neck cancer in Portugal – TRACE2 study

The microbiome-inflammation-immune axis in oral squamous cell carcinoma: from mechanistic insights to therapeutic perspectives